Loading stock analysis…
Evidence Synthesis
Last synthesized: 23 Aug 2026, 02:09
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
SOMANYCERA has accelerated its 48.49% to a new high, up from 7.69% over the last quarter.
The company's remains stable.
SOMANYCERA's revenue growth has slowed down to from 242.9% previously.
The stock's closing price has increased to from 511.1 INR, representing a daily gain.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 48.49 % | 7.69 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 7.69 % | 3.62 | ▲ |
| REVENUE_GROWTH_YOY | 24 % | 242.9 | ▼ |
| EPS_ACTUAL | 3.65 INR | 4.39 | ▼ |
| EPS_SURPRISE_PERCENT | -0.117 % | 0.135 | ▼ |
| PRICE_CHANGE_PERCENT | 1.771 % | — | - |
| DAILY_VOLUME | 1,63,937 shares | 1,62,181 | ▲ |
| CLOSE_PRICE | 520.15 INR | 511.1 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.94 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 3 count | 13 | ▼ |
| TARGET_PRICE_PREMIUM | 21.15 % | — | - |